208 related articles for article (PubMed ID: 22143067)
1. Surgical and chemotherapeutic options for urachal carcinoma: report of ten cases and literature review.
Yazawa S; Kikuchi E; Takeda T; Matsumoto K; Miyajima A; Nakagawa K; Oya M
Urol Int; 2012; 88(2):209-14. PubMed ID: 22143067
[TBL] [Abstract][Full Text] [Related]
2. [Clinical analysis of 14 cases of urachal carcinoma].
Chen ZF; Wang F; Qin ZK; Dai YP; Zhou FJ; Han H; Liu ZW; Yu SL; Li YH; Ye YL
Ai Zheng; 2008 Sep; 27(9):966-9. PubMed ID: 18799037
[TBL] [Abstract][Full Text] [Related]
3. [Prognosis in pT3b infiltrating tumors of the bladder treated by adjuvant chemotherapy].
Sahwi A; Robert M; Delbos O; Legouffe E; Guiter J; Navratil H
Prog Urol; 1998 Dec; 8(6):1007-11. PubMed ID: 9894259
[TBL] [Abstract][Full Text] [Related]
4. Small cell carcinoma of the urinary bladder. The Mayo Clinic experience.
Choong NW; Quevedo JF; Kaur JS
Cancer; 2005 Mar; 103(6):1172-8. PubMed ID: 15700264
[TBL] [Abstract][Full Text] [Related]
5. [A case of urachal carcinoma treated with S-1/CDDP combination chemotherapy].
Sekita N; Fujimura M; Arai H; Shibata N; Nishikawa R; Sugano I; Mikami K
Hinyokika Kiyo; 2010 Aug; 56(8):447-51. PubMed ID: 20808064
[TBL] [Abstract][Full Text] [Related]
6. Clinical outcome in patients with locally advanced bladder carcinoma treated with conservative multimodality therapy.
George L; Bladou F; Bardou VJ; Gravis G; Tallet A; Alzieu C; Serment G; Salem N
Urology; 2004 Sep; 64(3):488-93. PubMed ID: 15351577
[TBL] [Abstract][Full Text] [Related]
7. [A Case of Urachal Carcinoma Treated by TS-1/CDDP as Adjuvant Chemotherapy].
Inoue K; Shimada M; Saito K; Ogawa Y; Matsubara E; Matsumoto Y; Keiichiro H
Hinyokika Kiyo; 2015 Nov; 61(11):441-3. PubMed ID: 26699888
[TBL] [Abstract][Full Text] [Related]
8. Multimodality management of urachal carcinoma: the M. D. Anderson Cancer Center experience.
Siefker-Radtke AO; Gee J; Shen Y; Wen S; Daliani D; Millikan RE; Pisters LL
J Urol; 2003 Apr; 169(4):1295-8. PubMed ID: 12629346
[TBL] [Abstract][Full Text] [Related]
9. [Results of radical cystectomy for management of invasive bladder cancer with special reference to prognostic factors and quality of life depending on the type of urinary diversion].
Słojewski M
Ann Acad Med Stetin; 2000; 46():217-29. PubMed ID: 11712306
[TBL] [Abstract][Full Text] [Related]
10. Changing patterns of prognosticators during 15-year follow-up of advanced gastric cancer after radical gastrectomy and adjuvant chemotherapy: a 15-year follow-up study at a single korean institute.
Moon YW; Jeung HC; Rha SY; Yoo NC; Roh JK; Noh SH; Kim BS; Chung HC
Ann Surg Oncol; 2007 Oct; 14(10):2730-7. PubMed ID: 17632757
[TBL] [Abstract][Full Text] [Related]
11. Complete response of a recurrent advanced urachal carcinoma treated by S-1/cisplatin combination chemotherapy.
Kojima Y; Yamada Y; Kamisawa H; Sasaki S; Hayashi Y; Kohri K
Int J Urol; 2006 Aug; 13(8):1123-5. PubMed ID: 16903943
[TBL] [Abstract][Full Text] [Related]
12. Long-term survival after combined modality treatment in metastatic bladder cancer patients presenting with supra-regional tumor positive lymph nodes only.
de Vries RR; Nieuwenhuijzen JA; Meinhardt W; Bais EM; Horenblas S
Eur J Surg Oncol; 2009 Apr; 35(4):352-5. PubMed ID: 18722076
[TBL] [Abstract][Full Text] [Related]
13. The effect of cystectomy, and perioperative methotrexate, vinblastine, doxorubicin and cisplatin chemotherapy on the risk and pattern of relapse in patients with muscle invasive bladder cancer.
Ennis RD; Petrylak DP; Singh P; Bagiella E; O'Toole KM; Benson MC; Olsson CA
J Urol; 2000 May; 163(5):1413-8. PubMed ID: 10751847
[TBL] [Abstract][Full Text] [Related]
14. Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Research Consortium.
Shariat SF; Karakiewicz PI; Palapattu GS; Lotan Y; Rogers CG; Amiel GE; Vazina A; Gupta A; Bastian PJ; Sagalowsky AI; Schoenberg MP; Lerner SP
J Urol; 2006 Dec; 176(6 Pt 1):2414-22; discussion 2422. PubMed ID: 17085118
[TBL] [Abstract][Full Text] [Related]
15. External beam radiation therapy followed by interstitial radiotherapy with iridium-192 for solitary bladder tumours: results of 111 treated patients.
van Onna IE; Oddens JR; Kok ET; van Moorselaar RJ; Bosch JL; Battermann JJ
Eur Urol; 2009 Jul; 56(1):113-21. PubMed ID: 18722048
[TBL] [Abstract][Full Text] [Related]
16. Predictors of survival from urachal cancer: a Mayo Clinic study of 49 cases.
Molina JR; Quevedo JF; Furth AF; Richardson RL; Zincke H; Burch PA
Cancer; 2007 Dec; 110(11):2434-40. PubMed ID: 17932892
[TBL] [Abstract][Full Text] [Related]
17. Adjuvant chemotherapy for invasive urothelial cancer: experience with a methotrexate, vincristine, cisplatin, cyclophosphamide, adriamycin and bleomycin (MVP-CAB) regimen: a preliminary report.
Gohji K; Higuchi A; Maruyama S; Minayoshi K; Fujii A; Itoh N; Hasunuma Y; Tanaka H; Izumi T
Jpn J Clin Oncol; 1993 Oct; 23(5):291-8. PubMed ID: 7693990
[TBL] [Abstract][Full Text] [Related]
18. Can patient selection for bladder preservation be based on response to chemotherapy?
Sternberg CN; Pansadoro V; Calabrò F; Schnetzer S; Giannarelli D; Emiliozzi P; De Paula F; Scarpone P; De Carli P; Pizzo M; Platania A; Amini M
Cancer; 2003 Apr; 97(7):1644-52. PubMed ID: 12655521
[TBL] [Abstract][Full Text] [Related]
19. Radical cystectomy in the elderly: Comparison of survival between younger and older patients.
Clark PE; Stein JP; Groshen SG; Cai J; Miranda G; Lieskovsky G; Skinner DG
Cancer; 2005 Feb; 103(3):546-52. PubMed ID: 15630702
[TBL] [Abstract][Full Text] [Related]
20. Urachal carcinoma: contemporary surgical outcomes.
Herr HW; Bochner BH; Sharp D; Dalbagni G; Reuter VE
J Urol; 2007 Jul; 178(1):74-8; discussion 78. PubMed ID: 17499279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
